Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Signal Transduction and Targeted Therapy
|
November 19, 2025
Targeted complement inhibition ameliorates the pathological and cognitive outcomes in repetitive mild closed head injury
Khalil Mallah, Carsten Krieg, Devin Hatchell, et al.
Biomolecules
|
May 28, 2025
Modulating the CXCR2 Signaling Axis Using Engineered Chemokine Fusion Proteins to Disrupt Myeloid Cell Infiltration in Pancreatic Cancer
Benjamin N Christopher, Lena Golick, Ashton Basar, et al.
The Journal of Experimental Medicine
|
November 9, 2016
High-dimensional single-cell analysis reveals the immune signature of narcolepsy
Felix J Hartmann, Raphaël Bernard-Valnet, Clémence Quériault, et al.
Blood
|
August 22, 2013
Interleukin-7 is produced by afferent lymphatic vessels and supports lymphatic drainage
Maria Iolyeva, David Aebischer, Steven T Proulx, et al.
Cancer Immunology, Immunotherapy : CII
|
January 27, 2019
Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
Luca Cassetta, Espen S Baekkevold, Sven Brandau, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 19, 2025
A Th17 signature correlates with response to dual CTLA-4 and PD-1 blockade in metastatic renal cell carcinoma
Silvia Guglietta, Anne Bärenwaldt, Anthony Sonrel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 21, 2020
Circulating neutrophil subsets in advanced lung cancer patients exhibit unique immune signature and relate to prognosis
Merav E Shaul, Ophir Eyal, Silvia Guglietta, et al.
Nature
|
March 27, 2012
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'
Aron M Levin, Darren L Bates, Aaron M Ring, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2018
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response
Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, et al.
Journal of Crohn'S & Colitis
|
November 15, 2017
The Proton-activated Receptor GPR4 Modulates Intestinal Inflammation
Yu Wang, Cheryl de Vallière, Pedro H Imenez Silva, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Signal Transduction and Targeted Therapy
|
November 19, 2025
Targeted complement inhibition ameliorates the pathological and cognitive outcomes in repetitive mild closed head injury
Khalil Mallah, Carsten Krieg, Devin Hatchell, et al.
Biomolecules
|
May 28, 2025
Modulating the CXCR2 Signaling Axis Using Engineered Chemokine Fusion Proteins to Disrupt Myeloid Cell Infiltration in Pancreatic Cancer
Benjamin N Christopher, Lena Golick, Ashton Basar, et al.
The Journal of Experimental Medicine
|
November 9, 2016
High-dimensional single-cell analysis reveals the immune signature of narcolepsy
Felix J Hartmann, Raphaël Bernard-Valnet, Clémence Quériault, et al.
Blood
|
August 22, 2013
Interleukin-7 is produced by afferent lymphatic vessels and supports lymphatic drainage
Maria Iolyeva, David Aebischer, Steven T Proulx, et al.
Cancer Immunology, Immunotherapy : CII
|
January 27, 2019
Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
Luca Cassetta, Espen S Baekkevold, Sven Brandau, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 19, 2025
A Th17 signature correlates with response to dual CTLA-4 and PD-1 blockade in metastatic renal cell carcinoma
Silvia Guglietta, Anne Bärenwaldt, Anthony Sonrel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 21, 2020
Circulating neutrophil subsets in advanced lung cancer patients exhibit unique immune signature and relate to prognosis
Merav E Shaul, Ophir Eyal, Silvia Guglietta, et al.
Nature
|
March 27, 2012
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'
Aron M Levin, Darren L Bates, Aaron M Ring, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2018
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response
Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, et al.
Journal of Crohn'S & Colitis
|
November 15, 2017
The Proton-activated Receptor GPR4 Modulates Intestinal Inflammation
Yu Wang, Cheryl de Vallière, Pedro H Imenez Silva, et al.
Page
of 5